Hong Kong, Singapore, Shanghai, Sydney, London

Hong Kong, Singapore, Shanghai, Sydney, London

Valtech-Valuation-Consulting

Long Service Payment Valuation (LSP Valuation in Hong Kong)

In the sector of long service payment valuation, Valtech is truly professional and experienced. All of the track records we share with our clients are directly related to LSP valuation but not valuation of other nature. Valtech also provides further support in providing or reviewing figures for accounting disclosure such as sensitivity testing, discount rates etc.

Valtech Valuation Offers Specific Solutions and Advice to LSP Calculation to Ensure Compliance

Categories: Business Valuation, Long Service Payment Valuation (LSP Valuation in Hong Kong)|Tags: , , |

Discover tailored advice from Valtech Valuation for LSP calculations to ensure compliance and optimize your financial strategies.

LSP Valuation – Long Service Payments valuation under the New Legislations for Hong Kong Companies

Categories: Long Service Payment Valuation (LSP Valuation in Hong Kong), Financial Reporting IFRS HKFRS, HKAS, News|Tags: , |

Valtech Valuation Assists Hong Kong Companies in Long Service Payments (LSP) Valuation under the New Legislations to abolish offsetting against MPF contribution

Valtech’s Insight: The Importance of Assessing Long Service Payment Liability in Purchase Price Allocation

Categories: PPA Assessment, Business Valuation, Long Service Payment Valuation (LSP Valuation in Hong Kong), Valtech Insights|Tags: , , , , |

When companies engage in mergers and acquisitions (M&A), accurate financial due diligence is essential for a seamless transaction. One critical yet often overlooked aspect in this process is the assessment of long service payment liability (LSP liability) when performing purchase price allocation (PPA).

Valtech Valuation Completes Long Service Payment Valuation for a Medical Company

Categories: Long Service Payment Valuation (LSP Valuation in Hong Kong), Business Valuation|Tags: , , , |

Valtech's experienced team completes a LSP valuation for a medical company in Hong Kong. Learn more about the subsidy scheme and its impact.

Go to Top